Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Curr Eye Res. 2023 Jan 11;48(4):339–347. doi: 10.1080/02713683.2022.2162088

Table 6:

Descriptive statistics for dry eye symptoms and signs across levels of tear cytokines.

Median cytokine value N OSDI score Conjunctival staining score Corneal staining score TBUT Schirmer’s test
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)

IL-1β
 Q1 (0–1.1) 0 34 42.7 (18.1) 2.8 (1.2) 3.7 (2.4) 3.3 (1.2) 10.6 (6.6)
 Q2 (>1.1–3.5) 2.6 32 42.3 (16.5) 2.8 (1.3) 2.9 (2.5) 3.1 (1.3) 14.1 (7.8)
 Q3 (>3.5–5.5) 4.2 32 41.8 (13.3) 2.5 (1.3) 3.2 (2.5) 3.2 (1.2) 15.8 (10.0)
 Q4 (>5.5–39.4) 8.1 33 41.0 (13.4) 2.7 (1.3) 2.8 (2.6) 3.8 (2.1) 10.9 (6.9)
IL-6
 Q1 (0–3.1) 2.3 32 42.8 (17.9) 2.6 (1.1) 3.0 (2.7) 3.3 (1.4) 14.5 (8.2)
 Q2 (>3.1–5.4) 4.0 34 46.1 (14.4) 2.6 (1.2) 3.0 (2.7) 3.3 (1.6) 13.3 (8.9)
 Q3 (>5.4–9.5) 7.3 32 41.2 (14.7) 3.0 (1.5) 3.3 (2.5) 3.4 (1.3) 12.1 (8.1)
 Q4 (>9.5–470) 16.9 32 37.8 (13.6) 2.6 (1.3) 3.4 (2.3) 3.4 (1.8) 11.5 (7.2)
IL-8
 Q1 (0–15.1) 10.7 33 45.3 (14.7) 2.7 (1.2) 3.6 (2.6) 3.5 (1.7) 12.7 (7.6)
 Q2 (>15.1–33.8) 24.4 32 43.4 (15.6) 2.4 (1.2) 2.3 (2.7) 3.4 (1.3) 14.0 (9.5)
 Q3 (>33.8–96.2) 54.5 32 38.9 (15.2) 2.7 (1.2) 3.0 (2.2) 3.2 (1.4) 13.6 (8.6)
 Q4 (>96.2–15953) 339 33 39.9 (15.7) 3.1 (1.5) 3.7 (2.4) 3.3 (1.7) 11.0 (6.6)
IL-17A
 Q1 (0–1.6) 0 33 42.3 (15.7) 3.2 (1.4) 3.3 (2.4) 3.1 (1.0) 11.5 (7.3)
 Q2 (>1–8.0) 4.4 32 40.4 (15.9) 2.4 (1.0) 4.3 (2.6) 3.0 (1.2) 12.0 (7.1)
 Q3 (>8.0–12.3) 10.3 33 45.4 (15.7) 2.8 (1.4) 2.6 (2.4) 3.6 (1.6) 15.8 (10.1)
 Q4 (>12.3–47.7) 18.2 33 39.6 (14.0) 2.5 (1.2) 2.4 (2.3) 3.7 (1.9) 11.8 (7.1)
IL-10
 Q1 (0) 0 36 43.6 (17.0) 2.9 (1.1) 3.8 (2.4) 3.2 (1.2) 11.1 (6.4)
 Q2 (>0–8.0) 4.4 29 42.3 (14.4) 2.9 (1.5) 3.4 (2.6) 3.2 (1.1) 14.5 (8.6)
 Q3 (>8.0–16.2) 12.3 33 41.1 (16.5) 2.5 (1.3) 3.0 (2.5) 3.6 (2.1) 14.8 (9.1)
 Q4 (>16.2–70.3) 28.1 32 40.2 (13.3) 2.6 (1.3) 2.4 (2.5) 3.5 (1.5) 11.2 (8.0)
IFNγ
 Q1 (0–9.8) 4.0 33 41.4 (18.4) 3.0 (1.3) 4.4 (2.2) 3.0 (1.0) 10.3 (7.6)
 Q2 (>9.8–27.7) 18.3 33 43.6 (13.1) 2.7 (1.3) 3.4 (2.8) 3.0 (1.2) 13.0 (6.8)
 Q3 (>27.7–41.4) 33.7 33 43.3 (15.9) 2.7 (1.2) 2.3 (2.2) 3.8 (1.5) 16.1 (9.6)
 Q4 (>41.4–142) 64.2 32 39.5 (13.8) 2.4 (1.2) 2.6 (2.3) 3.7 (2.1) 11.7 (7.3)
TNFα
 Q1, Q2 (0) 0 70 42.6 (16.4) 2.8 (1.3) 2.7 (2.5) 3.4 (1.4) 14.2 (8.8)
 Q3 (>0–3.5) 1.9 28 43.4 (14.8) 2.5 (1.1) 4.5 (2.3) 2.9 (1.0) 11.5 (6.4)
 Q4 (>3.5–99.6) 6.5 32 39.6 (13.6) 2.6 (1.4) 3.1 (2.5) 3.6 (2.0) 10.9 (7.6)